EAM Investors’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
HRCM
CIP
EAM Investors's ATRC Position: Q2 2025 in Review
EAM Investors sold out of AtriCure (ATRC) in Q2 2025, closing a stake of 85,525 shares — an estimated $2.76M sold.
EAM Investors first reported a position in ATRC in Q3 2013 and held it in 14 quarters. The position peaked at $5.16M in Q3 2018. 201 funds tracked by Wall St. Rank hold ATRC as of Q2 2025.
- EAM Investors reported no remaining AtriCure position as of Q2 2025 after selling out during the quarter.
- EAM Investors sold 85,525 AtriCure shares in Q2 2025, an estimated $2.76M.
- EAM Investors first reported a position in AtriCure in Q3 2013 and held it in 14 quarters.
- EAM Investors's AtriCure position peaked at $5.16M in Q3 2018.
- 201 funds tracked by Wall St. Rank held AtriCure as of Q2 2025.
Based on EAM Investors's 13F filing for Q2 2025, filed 12 Aug 2025.